These findings support the roles of these two lipid-binding chaperones in the pathogenesis of vascular complications of diabetes, and provide possible perspective for using lipocalin-2 and RBP4 as biomarkers for early detection of high-risk individuals developing cardiovascular diseases and potential therapeutic targets for atherosclerosis. The gene discussed is LCN2; the disease is atherosclerosis.